Concentrix (NASDAQ:CNXC) Stock Price Down 5.4% After Earnings Miss

Concentrix Corporation (NASDAQ:CNXCGet Free Report)’s stock price fell 5.4% during mid-day trading on Wednesday following a weaker than expected earnings announcement. The company traded as low as $25.44 and last traded at $25.0570. 1,952,025 shares traded hands during trading, an increase of 33% from the average session volume of 1,467,669 shares. The stock had previously closed at $26.48.

The company reported $2.61 EPS for the quarter, missing analysts’ consensus estimates of $2.65 by ($0.04). Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.The firm had revenue of $2.50 billion during the quarter, compared to analysts’ expectations of $2.49 billion. During the same quarter in the prior year, the firm posted $2.79 earnings per share. Concentrix’s quarterly revenue was up 5.4% on a year-over-year basis.

Concentrix Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 5th. Stockholders of record on Friday, April 24th will be issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 5.8%. The ex-dividend date of this dividend is Friday, April 24th. Concentrix’s dividend payout ratio is -6.91%.

Key Concentrix News

Here are the key news stories impacting Concentrix this week:

  • Positive Sentiment: Board declared a quarterly dividend of $0.36/share (≈5.3% yield) payable May 5; signals shareholder returns even amid earnings pressure.
  • Positive Sentiment: Revenue and guidance: Q1 revenue rose to $2.50B (+5.4% YoY) and management maintained full‑year revenue and non‑GAAP EPS guidance; company highlighted AI/iX Suite enterprise momentum. Concentrix Reports First Quarter 2026 Results
  • Positive Sentiment: Share repurchases: repurchased ≈1M shares in Q1 at ~$40/share with ~$396.6M remaining authorization — supports per‑share value over time.
  • Neutral Sentiment: Liquidity/finance action: amended accounts receivable securitization facility — improves working‑capital flexibility but not a direct earnings driver. Concentrix Expands and Extends Accounts Receivable Securitization Facility
  • Neutral Sentiment: Company held its Q1 earnings call and published the transcript/slide deck for investors to review — useful for color on margin drivers and AI wins. Earnings Call Transcript
  • Neutral Sentiment: Short‑interest data in feeds appears inconsistent (reported as 0 shares) and should be treated with caution — no reliable signal from those entries.
  • Negative Sentiment: Q1 earnings and cash flow weakness: reported EPS $2.61 vs. consensus ~$2.65; GAAP net income plunged ~69% YoY, diluted EPS down 68%, operating and adjusted EBITDA margins compressed, and operating cash flow/adjusted free cash flow were negative — profit and cash‑flow deterioration raises near‑term risk. Q1 Press Release / Financials
  • Negative Sentiment: Analyst price‑target cuts: Barrington lowered target $62→$38, Canaccord cut $80→$55, Baird trimmed $52→$40 (ratings remain buy/outperform) — large downward PT revisions can pressure the stock and prompt re‑rating. Analyst Price Target Changes (Benzinga)
  • Negative Sentiment: Investor skepticism: recent commentary (e.g., Seeking Alpha) argues valuation/margin risks mean the stock isn’t an attractive buy even after the big multiple compression. Why I’m Not Buying Concentrix

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Barrington Research reduced their price target on shares of Concentrix from $62.00 to $38.00 and set an “outperform” rating on the stock in a research report on Wednesday. Robert W. Baird lowered their price objective on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating for the company in a research report on Wednesday. Wall Street Zen raised shares of Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Weiss Ratings downgraded shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a report on Thursday, January 29th. Finally, Canaccord Genuity Group decreased their target price on shares of Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a research report on Wednesday. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Concentrix presently has an average rating of “Hold” and a consensus price target of $48.50.

Check Out Our Latest Analysis on CNXC

Insiders Place Their Bets

In related news, CEO Christopher A. Caldwell purchased 1,000 shares of the stock in a transaction that occurred on Thursday, January 29th. The stock was bought at an average cost of $37.07 per share, for a total transaction of $37,070.00. Following the completion of the transaction, the chief executive officer directly owned 362,075 shares in the company, valued at $13,422,120.25. This represents a 0.28% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Hussman Strategic Advisors Inc. purchased a new position in shares of Concentrix during the 3rd quarter worth about $1,938,000. Allspring Global Investments Holdings LLC purchased a new stake in Concentrix in the 3rd quarter worth about $9,627,000. Capital Management Corp VA raised its position in Concentrix by 45.0% in the 3rd quarter. Capital Management Corp VA now owns 472,681 shares of the company’s stock worth $21,814,000 after purchasing an additional 146,688 shares during the period. Natixis bought a new stake in Concentrix in the second quarter worth about $1,872,000. Finally, Arrowstreet Capital Limited Partnership lifted its stake in Concentrix by 247.2% in the second quarter. Arrowstreet Capital Limited Partnership now owns 535,843 shares of the company’s stock worth $28,322,000 after purchasing an additional 381,497 shares during the last quarter. Institutional investors own 90.34% of the company’s stock.

Concentrix Stock Down 5.4%

The firm has a market cap of $1.54 billion, a PE ratio of -1.20, a price-to-earnings-growth ratio of 0.35 and a beta of 0.50. The company has a 50-day simple moving average of $35.34 and a 200-day simple moving average of $40.33. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.40 and a quick ratio of 1.40.

About Concentrix

(Get Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

Read More

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.